Publications found:
36,694
Sort by:
Gliosarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Gliosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Drugs In Development, 2021, provides an ov...
October 2021
575 pages
Neuroblastoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Neuroblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma - Drugs In Development, 2021, provides a...
October 2021
1265 pages
Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development, 20...
October 2021
4641 pages
Obesity (Metabolic Disorder) - Drugs in Development, 2021
US$ 2,500.00
Obesity (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an...
October 2021
763 pages
Pontine Glioma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Pontine Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Drugs In Development, 2021, provides...
October 2021
649 pages
Vaginal Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Vaginal Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Drugs In Development, 2021, provides...
October 2021
579 pages
Top 5 Pharmaceutical Companies - Company Chartbooks
US$ 150.00
Top 5 Pharmaceutical Companies - Company Chartbooks SUMMARY All markets and industries have been affected by COVID-19 - some have benefited financially while the majority of companies in every industr...
October 2021
15 pages
Vitamin China E-News 202109
US$ 3,186.00
... , a leading producer of sodium dichromate and VK3 in China. It is likely to start equipment overhauls and ... the raw material and product to some extent. VA prices rebounded in early period of this month as a result ... into vitamin APIs, with the VB5 and VB6 projects being advanced further. Vitamins China E-News is ...
October 2021
45 pages
Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generics), By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global antiviral drugs market is expected to reach a value of USD 69.2 billion by 2025, based on a new report by ... ). Introduction of efficient antiviral drugs with benefits such as rapid action, increased sensitivity, and lower adverse effects is expected to serve this market as a high-impact ...
October 2021
120 pages
Basal cell carcinoma - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Basal Cell Carcinoma (Basal Cell Epithelioma) The report also ...
October 2021
70 pages
Chondrosarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Chondrosarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chondrosarcoma development. The report provides detailed ...
October 2021
60 pages
Binge-eating disorder - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Binge Disorders - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Binge Disorders development. The report provides ...
October 2021
60 pages
Herpes labialis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Herpes Labialis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Herpes Labialis development. The report provides ...
October 2021
60 pages
Hypertriglyceridemia - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Hypertriglyceridemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypertriglyceridemia development. The report provides detailed ...
October 2021
60 pages
Liposarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Liposarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Liposarcoma development. The report provides detailed ...
October 2021
60 pages
Medulloblastoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Medulloblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Medulloblastoma development. The report provides detailed ...
October 2021
60 pages
Myelofibrosis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Myelofibrosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Myelofibrosis development. The report provides detailed ...
October 2021
80 pages
Peptic Ulcer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Peptic Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peptic Ulcers development. The report provides ...
October 2021
60 pages
Pulmonary Embolism - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Pulmonary Embolism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Embolism development. The report provides ...
October 2021
60 pages
Rosacea - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Rosacea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rosacea development. The report provides detailed ...
October 2021
60 pages
Narcolepsy - Pipeline Insight, 2021
US$ 1,500.00
... Narcolepsy - Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Narcolepsy. A detailed picture of the pipeline ... and Discontinued) Overview of pipeline development activities for Narcolepsy Pipeline analysis of therapeutic drugs include ...
October 2021
60 pages
Ataxia-telangiectasia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Ataxia-telangiectasia - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...
October 2021
60 pages
Beta-thalassaemia - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Beta-thalassaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+...
October 2021
60 pages
